| Literature DB >> 33802820 |
Jin Yang1, Lizhi Gong1, Miaomiao Guo2, Yu Jiang1, Yi Ding1, Zhijie Wang1, Xiujuan Xin1, Faliang An1.
Abstract
Six new prenylated indole diketopiperazine alkaloids, asperthrins A-F (1-6), along with eight known analogues (7-14), were isolated from the marine-derived endophytic fungus Aspergillus sp. YJ191021. Their planar structures and absolute configurations were elucidated by HR-ESI-MS, 1D/2D NMR data, and time-dependent density functional theory (TDDFT)/ECD calculation. The isolated compounds were assayed for their inhibition against three agricultural pathogenic fungi, four fish pathogenic bacteria, and two agricultural pathogenic bacteria. Compound 1 exhibited moderate antifungal and antibacterial activities against Vibrioanguillarum, Xanthomonas oryzae pv. Oryzicola, and Rhizoctoniasolani with minimal inhibitory concentration (MIC) values of 8, 12.5, and 25 μg/mL, respectively. Furthermore, 1 displayed notable anti-inflammatory activity with IC50 value of 1.46 ± 0.21 μM in Propionibacteriumacnes induced human monocyte cell line (THP-1).Entities:
Keywords: Aspergillus sp.; antimicrobial; endophytic fungus; indole diketopiperazine alkaloids
Year: 2021 PMID: 33802820 PMCID: PMC8002477 DOI: 10.3390/md19030157
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of 1–14.
1H (600 MHz) NMR Data of 1–6.
| Position | 1 a | 2 a | 3 a | 4 a | 5 a | 6 b |
|---|---|---|---|---|---|---|
| 1(NH) | 10.69 (s) | |||||
| 4 | 7.80 (d, 8.0) | 7.32 (d, 8.0) | 7.43 (d, 8.0) | 7.36 (d, 8.1) | 6.89 (d, 8.1) | 6.97 (d, 8.1) |
| 5 | 6.88 (d, 8.0) | 6.85 (d, 8.0) | 6.83 (d, 8.0) | 6.88 (d, 8.1) | 6.36 (d, 8.1) | 6.20 (d, 8.1) |
| 10 | 7.05 (s) | a 2.64 (d, 15.2) | 4.72 (s) | 4.12 (d, 1.2) | 5.75 (s) | a 2.72 (dd, 12.9, 7.0) |
| b 2.05 (d, 15.2) | b 2.59 (m) | |||||
| 11 | 4.59 (dd, 11.9, 7.0) | |||||
| 14 | a 3.40 (m) | a 3.34 (m) | 3.36 (m) | 3.40 (t, 6.5) | a 3.40 (m) | 3.56 (m) |
| b 3.34 (m) | b 3.29 (m) | b 3.30 (m) | ||||
| 15 | a 2.00 (m) | a 1.97 (m) | a 1.99 (m) | a 2.02 (m) | a 1.99 (m) | a 1.99 (m) |
| b 1.84 (m) | b 1.81 (m) | b 1.81 (m) | b 1.85 (m) | b 1.86 (m) | b 1.90 (m) | |
| 16 | a 2.53 (m) | a 2.50 (m) | a 2.54 (m) | a 2.54 (m) | a 2.48 (m) | a 2.33 (m) |
| b 1.83 (m) | b 1.83 (m) | b 1.81 (m) | b 1.85 (m) | b 1.80 (m) | b 2.10 (m) | |
| 19(NH) | 8.82 (s) | 7.52 (s) | 7.74 (s) | 7.87 (s) | 8.54 (s) | |
| 20 | a 2.21 (dd, 13.4, 10.2) | a 2.13 (m) | a 2.10 (dd, 13.2, 10.3) | a 2.02 (m) | a 2.04 (m) | a 3.64 (m) |
| b 1.89 (m) | b 1.85 (m) | b 1.75 (m) | b 1.85 (m) | b 1.79 (m) | b 3.56 (m) | |
| 21 | 2.31 (dd, 10.2, 5. 6) | 2.13 (m) | 3.08 (dd, 10.3, 6.5) | 3.53 (dd, 10.1, 7.8) | 2.68 (dd, 10.2, 6.5) | 3.81 (dd, 7.6, 2.8) |
| 23 | 1.22 (s) | 1.34 (s) | 1.31 (s) | 1.15 (s) | 0.52 (s) | 1.29 (s) |
| 24 | 1.55 (s) | 1.54 (s) | 1.32 (s) | 1.30 (s) | 1.12 (s) | 0.82 (s) |
| 25 | 7.74 (d, 10.2) | 7.83 (d, 10.2) | 7.78 (d, 10.2) | 7.76 (d, 10.1) | 6.57 (d, 9.8) | 6.15 (d, 9.9) |
| 26 | 5.96 (d, 10.2) | 5.90 (d, 10.2) | 5.92 (d, 10.2) | 5.93 (d, 10.1) | 5.75 (d, 9.8) | 5.50 (d, 9.9) |
| 28 | 1.42 (s) | 1.39 (s) | 1.41 (s) | 1.42 (s) | 1.38 (s) | 1.37 (s) |
| 29 | 1.41 (s) | 1.39 (s) | 1.39 (s) | 1.40 (s) | 1.35 (s) | 1.35 (s) |
| 31 | 2.03 (s) | |||||
| 3-OH | 6.39 (s) | 6.31 (s) | 6.27 (d, 1.2) | |||
| OMe-10 | 3.03 (s) | 3.31 (s) |
a Measured at 600 MHz (1H) in CDCl3; b measured at 600 MHz (1H) in DMSO-d6.
Figure 21H-1H COSY (bold blue lines) and key HMBC (red arrows) correlations for 1–6.
Figure 3Key ROESY correlations for 1–6.
Figure 4Experimental and calculated ECD spectra for 1–6. (A) for 1 and 5; (B) for 2; (C) for 3 and 4; (D) for 6.
13C (150 MHz) NMR Data of 1–6.
| Position | 1 a | 2 a | 3 a | 4 a | 5 a | 6 b |
|---|---|---|---|---|---|---|
| 2 | 145.4, C | 151.2, C | 153.3, C | 152.4, C | 176.3, C | 98.6, C |
| 3 | 132.7, C | 75.8, C | 78.5, C | 78.0, C | 64.3, C | 97.1, C |
| 4 | 121.7, CH | 121.9, CH | 123.1, CH | 124.2, CH | 125.0, CH | 125.2, CH |
| 5 | 116.3, CH | 116.7, CH | 116.1, CH | 116.9, CH | 108.7, CH | 108.0, CH |
| 6 | 155.1, C | 154.3, C | 154.2, C | 154.4, C | 152.5, C | 155.1, C |
| 7 | 111.4, C | 112.3, C | 112.0, C | 111.9, C | 104.8, C | 103.7, C |
| 8 | 139.6, C | 140.0, C | 140.9, C | 140.1, C | 138.0, C | 146.8, C |
| 9 | 117.6, C | 131.2, C | 129.3, C | 129.4, C | 124.6, C | 118.8, C |
| 10 | 121.8, CH | 36.0, CH2 | 76.9, CH | 76.1, CH | 74.1, CH | 38.9, CH2 |
| 11 | 60.3, C | 61.7, C | 62.1, C | 62.3, C | 68.9, C | 63.4, CH |
| 12 | 168.2, C | 168.4, C | 168.7, C | 168.5, C | 168.1, C | 167.1, C |
| 14 | 44.2, CH2 | 44.0, CH2 | 44.3, CH2 | 44.4, CH2 | 43.9, CH2 | 45.3, CH2 |
| 15 | 24.4, CH2 | 24.3, CH2 | 24.6, CH2 | 24.5, CH2 | 24.9, CH2 | 21.0, CH2 |
| 16 | 29.0, CH2 | 28.9, CH2 | 29.0, CH2 | 29.1, CH2 | 28.1, CH2 | 31.6, CH2 |
| 17 | 66.5, C | 66.8, C | 66.9, C | 66.8, C | 69.3, C | 93.6, C |
| 18 | 172.1, C | 172.4, C | 172.4, C | 172.2, C | 172.5, C | 165.4, C |
| 20 | 30.5, CH2 | 31.8, CH2 | 29.2, CH2 | 30.5, CH2 | 27.9, CH2 | 61.8, CH2 |
| 21 | 46.3, CH | 48.7, CH | 42.0, CH | 50.0, CH | 51.1, CH | 91.1, CH |
| 22 | 35.6, C | 38.6, C | 36.8, C | 36.6, C | 47.2, C | 46.7, C |
| 23 | 17.5, CH3 | 21.2, CH3 | 14.3, CH3 | 13.5, CH3 | 25.6, CH3 | 21.2, CH3 |
| 24 | 23.4, CH3 | 27.0, CH3 | 22.9, CH3 | 22.8, CH3 | 21.3, CH3 | 18.2, CH3 |
| 25 | 115.8, CH | 116.3, CH | 116.0, CH | 115.9, CH | 117.2, CH | 116.6, CH |
| 26 | 133.7, CH | 133.2, CH | 133.3, CH | 133.5, CH | 130.8, CH | 129.1, CH |
| 27 | 77.1, C | 76.5, C | 76.6, C | 76.7, C | 76.3, C | 76.0, C |
| 28 | 27.9, CH3 | 27.8, CH3 | 27.9, CH3 | 27.9, CH3 | 28.8, CH3 | 28.2, CH3 |
| 29 | 27.9, CH3 | 27.8, CH3 | 27.8, CH3 | 27.9, CH3 | 27.9, CH3 | 27.6, CH3 |
| 30 | 170.0, C | |||||
| 31 | 21.0, CH3 | |||||
| 10-OMe | 61.8, CH3 | 60.0, CH3 |
a Measured at 150 MHz (13C) in CDCl3; b measured at 150 MHz (13C) in DMSO-d
Antimicrobial activities of compounds 1–14 (MIC, μg/mL).
| No. | Bacteria | Fungi | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Xe | Xa | Et | Va | Ah | Vp | Rs | Fo | Cg | |
|
| 50 | 12.5 | 16 | 8 | 32 | 16 | 100 | >100 | >100 |
|
| >100 | >100 | — | — | — | — | 25 | >100 | >100 |
|
| >100 | >100 | — | — | — | — | 25 | >100 | >100 |
|
| >100 | >100 | — | — | — | — | 25 | >100 | >100 |
| Chloromycetin | 12.5 | 12.5 | 2 | 0.5 | 2 | 2 | — | — | — |
| Ketoconazole | — | — | — | — | — | — | 0.78 | 100 | 12.5 |
Xe: Xanthomonas oryzae pv. oryzae; Xa: Xanthomonas oryzae pv. oryzicola; Et: Edwardsiella tarda; Va: Vibrio anguillarum; Ah: Aeromonas hydrophilia; Vp: Vibrio parahaemolyticus; Rs: Rhizoctonia solani; Fo: Fusarium oxysporum; Cg: Colletotrichum gloeosporioides.
Anti-inflammatory activities of tested compounds.
| No. | THP-1 Cells |
| |
|---|---|---|---|
| IC50 (μM) | SC (μM) | MIC (μM) | |
|
| 1.46 ± 0.21 | 0–5 | >5 |
|
| 30.5 ± 0.2 | 0–40 | >40 |
|
| 37.2 ± 3.1 | 0–50 | >50 |
|
| 41.6 ± 1.3 | 0–50 | >50 |
|
| 46.2 ± 2.2 | 0–50 | >50 |
|
| 34.3 ± 1.6 | 0–50 | >50 |
| Tretinoin | 3.38 ± 0.28 | 0–50 | >50 |
SC: Safe concentration, indicating the concentration range of THP-1 cells viability over 80% treated by tested compounds.